15th World Congress on Heart Disease
       

Cardiology Online

Home

Welcome

Scientific Committees

Timetable

Program Topics

Program

Opening Lecture

International Academy of Cardiology Awards

IAC Distinguished Fellowship Awards

General Information

Abstract Guidelines

Instructions for the Preparation of Posters

Accommodation

Exhibition

Contact Us

Click here to download List of Scientific Presentations - Program (pdf)

 

  

final program

Sunday,
July 25, 2010		 Monday,
July 26, 2010		 Tuesday,
July 27, 2010
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions


Monday, July 26, 2010

MONDAY, JULY 26, 2010
08:30 - 10:15   HALL A
 

PL07        Plenary Session
ADVANCES IN THE TREATMENT OF ANEURYSM / THORACIC AORTIC PATHOLOGY
Chairpersons:
 J. Elefteriades, New Haven, CT, USA
S.D. Gertz, Jerusalem, Israel

  
08:30 ASSESSMENT OF VASCULAR FUNCTION IN PAEDIATRIC CARDIOLOGY: AN IMPORTANT EMERGING CLINICAL AREA (Invited Lecture)
G. Sandor, University of British Columbia, Vancouver, BC, Canada 		177
08:45 MANAGEMENT OF CARDIOVASCULAR DISEASE IN TURNER SYNDROME (Invited Lecture)
A.T. Yetman, Primary Children's Medical Center, Salt Lake City, UT, USA 		178
09:00 RECENT ADVANCES IN THE TREATMENT OF ABDOMINAL AORTIC ANEURYSM: ROLE OF PHOTOTHERAPY (Invited Lecture)
S. David Gertz, The Hebrew University -Hadassah Medical School, Jerusalem, Israel 		179
09:15 CONCURRENT INTRACRANIAL AND THORACIC AORTIC ANEURYSMS (Invited Lecture)
G.A. Kuzmik, M. Feldman, M. Tranquilli, J.A. Rizzo,
M. Johnson, J. Elefteriades, Yale University School of Medicine, New Haven, CT, USA 		180
09:30 UPDATE ON MECHANISMS, MARKERS AND NON-SURGICAL THERAPIES FOR AORTIC ANEURYSM (Invited Lecture)
J. Golledge, James Cook University, School of Medicine, Queensland, Australia 		181
09:45

MAST CELL PROTEASES CONTRIBUTE TO ABDOMINAL AORTIC ANEURYSM FORMATION IN MICE
(Invited Lecture)
G-P. Shi, Brigham and Women's Hospital, Boston, MA, USA  

 182
10:00 COMBINED SURGERY OF ACUTE TYPE A AORTIC DISSECTIONS BY ASCENDING AORTA REPLACEMENT AND BARE STENT
B. Leobon, D. Roux, S. Saccani, Y. Glock,
G. Fournial Department of Cardiovascular Surgery B, CHU De Rangueil, Toulouse, France 		183
10:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
08:30 - 10:45   HALL B
 

PL08:     Plenary Session
 PATHOGENESIS OF ATHEROSCLEROSIS 
Chairpersons:
M. Aikawa, Boston, MA, USA
M. Takahashi, Tochigi, Japan

 
08:30 DEDUCING THE MECHANISM OF DISEASES THROUGH EXPERIMENTAL THERAPY (Invited Lecture)
M. Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 		184
08:45 ROLE OF INFLAMMASOME IN CARDIOVASCULAR DISEASES (Invited Lecture)
M. Takahashi, Jichi Medical University, Tochigi, Japan 		185
09:00

NOVEL MECHANISMS OF MACROPHAGE ACTIVATION AND CARDIOMETABOLIC DISORDERS (Invited Lecture)
M. Aikawa, Brigham and Women's Hospital, Boston, MA, USA

186
09:15

DEFICIENCY OF TDAG51 IN APOE-DEFICIENT MICE REDUCES ATHEROGENESIS (Invited Lecture)
G.S. Hossain, J. Zhou, E. Lynn, K. Maclean,
B. Trigatti, S. Lhotak, D. Tang, J. Dickhout, R.C. Austin, McMaster University, Hamilton, Ontario, Canada

187
09:30 THE ROLE OF DNA DAMAGE RESPONSE IN ATHEROSCLEROSIS AND VASCULAR SMOOTH MUSCLE CELL APOPTOSIS (Invited Lecture)
T. Ishida, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan 		188
09:45 MODULATION OF THE ATHEROSCLEROTIC PLAQUE BY SHEAR STRESS (Invited Lecture)
S. Lehoux, Lady Davis Institute McGill University, Montreal, QC, Canada 		189
10:00 IS APOB100 INNOCENT IN ATHEROSCLEROSIS? IDENTIFICATION OF AN APOB100 DERIVED CHEMOTACTIC PEPTIDE FOR HUMAN INFLAMMATORY CELLS (Invited Lecture)
Z-Q. Yan, Karolinska Institute, Stockholm, Sweden 		190
10:15 THE ROLE OF PLASMACYTOID DENDRITIC CELLS IN PLAQUE DESTABILIZATION (Invited Lecture)
A. Niessner, Medical University of Vienna, Austria 		191
10:30 C-REACTIVE PROTEIN MEDIATED VASCULAR INJURY REQUIRES COMPLEMENT
A.J. Szalai, M.A. McCrory, F.G. Hage, S. Oparil,
D. Xing, Y.F. Chen, The University of Alabama at Birmingham, Birmingham, AL, USA 		192
10:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
08:30 - 10:15   HALL C
 

S27   Session
NEW DIAGNOSTIC METHODS AND IMAGING TECHNIQUES
Chairpersons:
E. Aikawa, Boston, MA, USA
Y. Seino, Inzai, Chiba, Japan

 
08:30 REGADENOSON INDUCES COMPARABLE LEFT VENTRICULAR PERFUSION DEFECTS AS ADENOSINE: A QUANTITATIVE ANALYSIS FROM THE ADVANCE MPI 2 TRIAL
J.J. Mahmarian, M.D. Cerqueira, A.E. Iskandrian,
T.M. Bateman, G.S. Thomas, R.C. Hendel,
L.A. Moye, A.W. Olmsted, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA 		193
08:45 MYOCARDIAL PERFORMANCE INDEX BY TISSUE DOPPLER IMAGING M-MODE PREDICTS MORTALITY IN THE GENERAL POPULATION
R. Mogelvang, T. Biering-Sorensen, S. Haahr-Pedersen, P. Schnohr, P. Sogaard, J.S. Jensen, Holbaek University Hospital, Holbaek, Denmark 		194
09:00 SAFETY OF REGADENOSON IN CHRONIC KIDNEY DISEASE PATIENTS
K. Ananthasubramaniam, G. Palani, Z. Husain,
A. Karthikeyan, V. Karthikeyan Henry Ford Hospital, Detroit, MI, USA 		195
09:15 LAMBL’S EXCRESCENCES IN A COMMUNITY POPULATION VERSUS REFERRAL POPULATION: DO THEY INCUR A RISK OF EMBOLIC EVENTS?
M.J. Ansari, C. Shub, M. Grogan, W.D. Edwards,
I. Meissner, B. Khandheria, K.W. Klarich, University Hospitals, Case Medical Center, Cleveland, OH, USA 		196
09:30 DISCOVERY OF ISCHEMIA BY MULTIPLE VARIABLES
J.C. Maganis, D.A. Drimmer, F.B. Rojo,
R.H.S. Selvester, M.H. Ellestad Long Beach Memorial Medical Center, Long Beach, USA 		197
09:45 ROBOTIC-ASSISTED LOCOMOTION TRAINING IMPROVES LEFT VENTRICLE DIASTOLIC FUNCTION AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH LOST SENSORIMOTOR FUNCTION: AN ECHOCARDIOGRAPHIC STUDY
S. Sitia, L. Tomasoni, I. Bo, L. Gianturco,
V. Magagnin, E. Caiani, M. Turiel Cardiology Unit, Department of Health Technologies, IRCCS Galeazzi Orthopedic Institute, University of Milan, Italy 		199
10:00 QTC PROLONGATION DURING VASODILATOR NUCLEAR STRESS TEST (NST) AND ITS ASSOCIATION WITH ABNORMAL SCAN AND ALL CAUSE MORTALITY IN AN INNER-CITY HOSPITAL
N.C. Bhalodkar, M. Atoui, R. Alvi, A. Gardezi,
U. Khan, N. Paladugu, S. Blum Bronx-Lebanon Hospital Center, Bronx, NY, USA; Affiliated with Albert Einstein College of Medicine  		 200
10:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
08:30 - 10:30   HALL D
  S28       Session
SECONDARY PREVENTION, MODIFICATION OF LIPOPROTEINS, PROGNOSIS, RISK STRATIFICATION
 Chairpersons:
R. Krittayaphong, Bangkok, Thailand
R. Manfredini, Lagosanto, Italy

 
08:30 NATIONAL SERVICE FRAMEWORK FOR CORONARY HEART DISEASE IN ENGLAND: 10 YEARS OF IMPEMENTATION
H. Swanton, R. Boyle, The Heart Hospital, London, UK 		201
08:45 PREVALENCE AND MANAGEMENT OF CARDIOVASCULAR DISEASE RISK FACTORS IN VON WILLEBRAND DISEASE PATIENTS
M.Y. Lim, A. Eckerman, K. Schmidt, R. Pruthi, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA 		202
09:00 THE EFFECT OF CORONARY ARTERY DISEASE ON THE HEART RATE RESPONSE DURING A VALSALVA MANEUVER
S.A. Atapattu, G. Robalino, A. Badiye, C. Marin,
E. de Marchena, University of Miami, Miami, FL, USA 		203
09:15 DEPRESSION SUBTYPES, INFLAMMATION, AND NEW CORONARY HEART DISEASE (CHD) EVENTS IN PATIENTS WITH KNOWN CHD
J.A. Shaffer, K.W. Davidson, D. Shimbo, Columbia University Medical Center, New York, NY, USA 		204
09:30 THE TRIGLYCERIDE BUT NOT THE CHOLESTEROL CONTENT OF HDL IS ASSOCIATED WITH SIGNS AND SYMPTOMS OF STATIN INTOLERANCE
T. Bouhali, K. Tremblay, M. Santure, J. Methot,
L. Bouchard, D. Brisson, D. Gaudet Ecogene-21, Universite de Montreal, Chicoutimi, QC, Canada 		205
09:45 EFFECT OF INTENSIVE LIFESTYLE CHANGES ON ENDOTHELIAL FUNCTION AND ON INFLAMMATORY MARKERS OF ATHEROSCLEROSIS
H.S. Dod, R. Bhardwaj, V. Sajja, G. Weidner,
G. Hobbs, N.C. Nanda, B.E. Warden, R.J. Beto,
D. Ornish, A.C. Jain, WVUH Morgantown, WV, USA  		 206
10:00 STABLE NUCLEIC ACID LIPID PARTICLE MEDIATED GENE SILENCING AMELIORATES ATHEROGENIC HYPERLIPIDEMIA IN MICE
M.L.E. MacDonald, J. Kaldestad, K. McClintock,
A. Dhillon, M.L. Eisenhardt, C. Kwok, D. Le,
J.R. Phelps, I. MacLachlan, A.C.H. Lee, Tekmira Pharmaceuticals Corporation, Burnaby, BC, Canada 		207
10:15 PARADOXICAL SYSTOLIC BLOOD PRESSURE INCREASE AFTER GRADED EXERCISE PREDICTS SEVERE CORONARY ARTERY DISEASE AND ALL-CAUSE MORTALITY
T.C. Su, M.F. Chen, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan 		208
10:30 STATINS DO NOT AFFECT LDL AND HDL SUBFRACTIONS AND THEIR PARTICLE SIZES AMONG ASIAN INDIANS
N.C. Bhalodkar, J. Loganathan, A. Mehta,
D. Purwaha, S. Blum Bronx Lebanon Hospital Center, Albert Einstein College of Medicine, NY, USA 		209
10:45 EFFECT OF LOW DENSITY LIPOPROTEIN APHERESIS ON PLASMA LEVELS OF APOLIPORPTEIN E4
P.M. Moriarty, J.P. Luyendyk, C.A. Gibson,
J.M. Backes University of Kansas, Kansas City, KS, USA 		210
11:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
11:00- 13:15   HALL A
 

PL09:          Plenary Session   
INSIGHTS INTO THE MECHANISM AND MANAGEMENT OF ATRIAL FIBRILLATION / STROKE PREVENTION
Chairperson:
A. Ducharme, Quebec, Canada

 
11:00 CARDIAC CONSEQUENCES OF ALTERED SIGNAL TRANSDUCTION IN ATRIAL FIBRILLATION
(Invited Lecture)
A. Goette, St. Vincenz-Hospital, Paderborn, Germany 		212
11:15 MRI FOR AF MANAGEMENT: STAGING AF AND BEYOND (Invited Lecture)
N. Marrouche, University of Utah Health Sciences Center, Salt Lake City, UT, USA 		213
11:30 LEFT ATRIAL APPENDAGE OCCLUSION (Invited Lecture)
H. Sievert, Cardiovascular Center Frankfurt, Germany 		214
11:45 NEW DEVELOPMENTS IN ANTICOAGULATION IN ATRIAL FIBRILLATION (Invited Lecture)
A. Martinez-Rubio, Hospital de Sabadell, Barcelona, Spain 		215
12:00 TELEMEDICINE FOR DIAGNOSING AND MANAGING PAROXYSMAL ATRIAL FIBRILLATION IN OUTPATIENTS: THE PHONE, NOT THE PILL, IN THE POCKET
 (Invited Lecture)
A. Roth, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel 		216
12:15 THE EMERGING USE OF CRYOABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION (Invited Lecture)
P.G. Guerra, Montreal Heart Institute, Canada 		217
12:30 CARDIAC REMODELING WITH RHYTHM VERSUS RATE CONTROL STRATEGIES FOR ATRIAL FIBRILLATION IN PATIENTS WTH HEART FAILURE: INSIGHTS FROM THE AF-CHF ECHOCARDIOGRAPHIC SUB-STUDY
(Invited Lecture)
A. Ducharme, Montreal Heart Institute, Quebec, Canada 		218
12:45 ABLATION OF ATRIAL FIBRILLATION USING A NOVEL UNI- AND BIPOLAR RADIOFREQUENCY ENERGY ABLATION SYSTEM (Invited Lecture)
T. Deneke, University of Bochum, Germany 		219
13:00 CAVOTRICUSPID ISTHMUS CATHETER ABLATION WITHOUT THE USE OF FLUOROSCOPY
L. Tercedor, M. Alvarez, R.S. Galdeano, L. Munoz,
F. Valverde, R. Penas, R. Melgares, University Hospital Virgen de las Nieves, Granada, Spain 		220
13:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 26, 2010
10:45 - 12:30   HALL B
 

PL10:     Plenary Session   
 OXIDATIVE STRESS AND INFLAMMATION IN CARDIOVASCULAR DISEASE
Chairpersons:
D.D. Heistad, Iowa City, IA, USA
K.A. Pritchard Jr., Milwaukee, WI, USA

 
10:45 PATHOPHYSIOLOGY OF AORTIC STENOSIS: ROLE OF OXIDATIVE STRESS (Invited Lecture)
D.D. Heistad, University of Iowa College of Medicine, Iowa City, IA, USA 		221
11:00 LOX-1 IN CARDIOVASCULAR DYSFUNCTION
(Invited Lecture)
T. Sawamura, National Cardiovascular Center Research Institute, Suita, Osaka, Japan 		222
11:15 REGULATION OF NAD(P)H OXIDASE BY HEMODYNAMIC FORCES: IMPACT ON ARTERIOSCLEROSIS (Invited Lecture)
H. Morawietz, Dresden University of Technology, Dresden, Germany 		223
11:30 NOVEL MYLEOPEROXIDASE INHIBITORS INHIBIT LDL OXIDATION AND IMPROVE VASODILATATION
(Invited Lecture)
K.A. Pritchard Jr., Medical College of Wisconsin, Milwaukee, WI, USA 		224
11:45 CRP AND CARDIOVASCULAR DISEASE: USE IN CLINICAL PRACTICE? (Invited Lecture)
B.G. Nordestgaard, Copenhagen University, Denmark 		225
12:00 HSP60, INFLAMMATION AND CARDIOVASCULAR DISEASE (Invited Lecture)
A.A. Knowlton, University of California, Davis, CA, USA 		226
12:15 THE ALTERATION OF THE BIOENERGETIC PATHWAY AGGRAVATES ATHEROSCLEROSIS IN PARAOXONASE-2 DEFICIENCY MICE
A. Devarajan, N. Bourquard, S. Morvardi, C. Clarke,
V. Grijalva, D. Meriwether III, J.F. Teiber, L. Vergnes,
K. Reue, S.T. Reddy The University of Texas Southwestern Medical Center, Dallas, Texas, USA 		228
12:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 26, 2010
10:45 - 13:30   HALL C
 

S29     Session
 NEW INSIGHTS INTO THE PATHOGENESIS AND TREATMENT OF CARDIOMYOPATHIES
Chairperson:
R.K. Goyal, Gujarat, India       

  
10:45 RISK FACTORS FOR TOTAL HEART BLOCK AFTER TRANSCORONARY ABLATION OF SEPTAL HYPERTROPHY
T. Lawrenz, M. Schloesser, M. Bartelsmeier,
C. Leuner, C. Strunk-Mueller, D. Meyer zu Vilsendorf,
H. Kuhn, C. Stellbrink, Klinikum Bielefeld-Mitte, Bielefeld, Germany 		230
11:00 EARLY DYSTROPHIN DISRUPTION IN THE PATHOGENESIS OF EXPERIMENTAL CHRONIC CHAGAS CARDIOMYOPATHY
C.M. Prado, M.R.N. Celes, L.M. Malvestio,
E.C. Campos, L.A. Jelicks, H.B. Tanowitz,
M.A. Rossi, Faculty of Medicine of Ribeirao Preto, USP, Brazil 		231
11:15 A SERVO-CONTROLLED CANINE MODEL OF STABLE SEVERE ISCHEMIC LEFT VENTRICULAR FAILURE
R.L. Wagner, W.B. Hood, Jr., P.A. Howland, Harvard University, Boston, MA, USA 		232
11:30 OCCULT ENDOCARDIAL THROMBOSIS IN IDIOPATHIC LEFT VENTRICULAR DYSFUNCTION
A. Frustaci, P. Severino, E. Canali, C. Centurion,
M. Mancone, R. Verardo, F. Fedele, C. Chimenti, La Sapienza University, Rome, Italy 		233
11:45 EFFECT OF WEIGHT LOSS ON VENTRICULAR REPOLARIZATION IN MORBIDLY OBESE PATIENTS
R. Mukerji, M.A. Alpert, University of Missouri Health Sciences Center, Columbia, MO, USA 		234
12:00 EFFECT OF ADAPTIVE SERVO VENTILATOR ON CARDIAC FUNCTION IN NORMAL AND HEART DISEASE SUBJECTS
T. Taguchi, H. Adachi, J. Murakami, E. Yamashita,
R. Kawaguchi, T. Toyama, S.Naito, H. Hoshizaki,
S. Oshima, Gunma Prefectural Cardiovascular Center, Maebashi, Gunma, Japan 		235
12:15 SUPPRESSION OF MYOCARIAL HYPERTROPHY BY PHOSPHODIESTERASE–5 INHIBITORS: THE ROLE OF CALCINEURIN AND P 38 MAPK
S.Y. Khatib, A. Zeidan, M. Al-Jinabi, A. Badwan, Jordan University of Science and Technology, Irbid, Jordan  		 236
12:30 ACCURACY OF ECG CRITERIA FOR THE DIAGNOSIS OF LEFT VENTRICULAR HYPERTROPHY
R. Krittayaphong, V. Nomsawadi, M. Muenkaew,
M. Miniphan, Siriraj Hospital, Bangkok, Thailand  		 237
12:45 COMPLICATIONS OF LOW-DOSE, ECHO-GUIDED ALCOHOL SEPTAL ABLATIONS FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
J. Veselka, D. Zemanek, P. Tomasov, S. Homolova,
R. Adlova, CardioVascular Center, University Hospital Motol, Prague, Czech Republic  		 238
13:00 PREDICTORS OF LEFT VENTRICULAR MASS AMONG PREDOMINANTLY HISPANIC AND AFRICAN AMERICAN PATIENTS WITH DIABETES MELLITUS IN AN INNER CITY HOSPITAL
N.C. Bhalodkar, H. Chelimilla, A. Garg, L. Vicioso,
S. Srikakarlapudi, A.M. Limaye, S. Blum, J.N. Bella, Bronx 		239
13:15 THE EFFECT OF ETHNICITY ON COMPUTERIZED ELECTROCARDIOGRAM MEASUREMENT OF COLLEGE ATHLETES
J. Sadik, M.G. Gademan, M.J. Lipinski, D. Sedehi,
E.A. Ashley, V.F. Froelicher Palo Alto Veterans Affairs Medical Center / Stanford University, Palo Alto, CA, USA  		 240
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 26, 2010
11:00 - 13:30   HALL D
  S30     Session
 ATHEROSCLEROSIS: PRIMARY PREVENTION, RISK ASSESSMENT
Chairpersons:
G.L. Fung, San Francisco, CA, USA
M. Yokota, Nagoya, Japan		  
11:00 IMPACT OF KIDNEY DISEASE AND BLOOD PRESSURE ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASE: RESULTS FROM THE JAPAN ARTERIOSCLEROSIS LONGITUDINAL STUDY
T. Ninomiya, Y. Kiyohara, Y. Tokuda, Y. Doi,
H. Arima, A. Harada, Y. Ohashi, H. Ueshima, Kyushu University, Fukuoka, Japan 		241
11:15 RELATIONSHIP BETWEEN DEPRESSION AND C-REACTIVE PROTEIN LEVELS AND FIRST CORONARY HEART DISEASE EVENT
K.W. Davidson, J.A. Shaffer, J.E. Schwartz,
S.A. Kirkland, E. Mostofsky, D. Fink, D. Guernsey,
D. Schimbo, Department of Medicine, Columbia University Medical Center, NY, USA 		242
11:30 CAROTID DIAMETER IMPROVES THE CAROTID IMT CAPACITY TO PREDICT CORONARY EVENTS: DATA FROM THE IMPROVE STUDY
D. Baldassarre, M. Amato, E. Tremoli, on behalf of the IMPROVE study group Department of Pharmacological Sciences, University of Milan, Italy 		243
11:45 MORTALITY AND MORBIDITY FROM CORONARY HEART DISEASE IN GERMANY ATTRIBUTABLE TO PASSIVE SMOKING
J. Heidrich, J. Wellmann, P. Heuschmann, U. Keil, University of Muenster, Germany, Charite Universitaetsmedizin Berlin, Germany 		244
12:00 CAROTID INTIMA MEDIAL THICKNESS (CIMT) AND SMALL ARTERY ELASTICITY (C2) AS A POWERFUL TOOL FOR CARDIOVASCULAR DISEASE (CVD) RISK STRATIFICATION AS COMPARED WITH HIGH-SENSITIVITY C-REACTIVE PROTEIN (HCRP) REGARDLESS OF SEX
M. El Shahawy, M. Entcheva, J.N. Cohn, Sarasota Memorial Hospital, Sarasota, Fl, USA 		245
12:15 HOUSEHOLD FOOD INSECURITY AND OCCURRENCE OF CARDIAC RISK FACTORS IN YOUNG: WHO IS AT RISK?
A. Bajaj, D.D. Ramdath, M. Moghadasian,
P.K. Singal, St. Boniface General Hospital Research Centre, University of Manitoba, Winnipeg, MB, Canada 		246
12:30 AGGRESSIVE TREATMENT OF CARDIOVASCULAR RISK FACTORS RESULTS IN THE REDUCTION OF ATHEROSCLEROSIS GROWTH AS MEASURED BY CAROTID INTIMA MEDIA THICKNESS: EXPERIENCE FROM AN ATHEROSCLEROSIS PREVENTION CLINIC
D.M. Eldringhoff, J.M. Backes, J.F. Ruisinger,
J.S. Dutton, B.J. Barnes, J.M. Belmont, P.M. Moriarty, Kansas University Medical Center, Kansas City, KS, USA 		247
12:45 ACUTE MYOCARDIAL INFARCTION IN YOUNG: WHO IS AT RISK?
S. Bajaj, N. Gupta, R. Parikh, N. Parikh, O. Alrabadi,
A. Hamdan, M. Bikkina, F. Shamoon St. Joseph's Regional Medical Center, Paterson, New Jersey, USA 		248
13:00 HDL/APO B RATIO EQUAL OR GREATER THAN 1 AS A POTENTIAL TARGET FOR PREVENTION AND REVERSAL OF CARDIOVASCULAR DISEASE?
K.J. Reddy, M. Singh, R.R. Batsell, R.A. Miraskar,
J.R. Bangit Reddy Cardiac Wellness, Sugarland, TX, USA 		249
13:15 INVERSE CORRELATION BETWEEN BMI AND CORONARY ANGIOGRAPHIC FINDINGS IN AN INNER-CITY MINORITY POPULATION
H. Shaqra, N. Fida, J. Loganathan, T. Haque,
M.U. Anwer, S. Blum, S.S. Chilimuri, N. Bhalodkar Bronx Lebanon Hospital Centre Affiliated with Albert Einstein College of Medicine, Bronx, NY, USA 		250
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 26, 2010
14:00 - 16:15   HALL A
  PL11     Plenary Session
 NEW CONCEPTS IN CARDIAC REMODELING AND MYOCARDIAL PROTECTION
Chairpersons:
N.S. Dhalla, Winnipeg, MB, Canada
H.N. Sabbah, Detroit, MI, USA
 
14:00 SUBCELLULAR REMODELING IN CONGESTIVE HEART FAILURE DUE TO MYOCARDIAL INFARCTION
(Invited Lecture)
N.S. Dhalla, International Academy of Cardiovascular Sciences, Winnipeg, Manitoba, Canada 		287
14:25 ALGINATES FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION AND HEART FAILURE (Invited Lecture)
H.N. Sabbah, Henry Ford Hospital, Detroit, MI, USA 		288
14:30 AUTOPHAGY IN THE ISCHEMIC HEART (Invited Lecture)
D.K. Das, University of Connecticut Medical Center, Farmington, CT, USA 		289
14:45 AGING AND MODULATION OF THE RENIN-ANGIOTENSIN-SYSTEM POST INFARCTION
(Invited Lecture)
B.I. Jugdutt, University of Alberta Hospitals, Edmonton, AL, Canada 		290
15:00 PLEIOTROPIC EFFECTS OF PIOGLITAZONE AFFECTING MYOCARDIAL PROTECTION AGAINST ISCHEMIA-REPERFUSION INJURY (Invited Lecture)
Y. Ye, J.R. Perez-Polo, Y. Birnbaum, Baylor College of Medicine, Houston, TX, USA 		291
15:15 INHIBITION OF MALONYL COA DECARBOXYLASE PREVENTS ADVERSE CARDIAC REMODELLING POST-INFARCTION (Invited Lecture)
G. Lopaschuk, University of Alberta, Edmonton, AL, Canada  		 292
15:30 CARDIOPROTECTIVE ACTION OF OXYTOCIN: POSSIBLE ROLE IN STRESS (Invited Lecture)
D. Jezova, Slovak Academy of Sciences, Bratislava, Slovakia 		293
15:45 REMOTE ISCHEMIC CONDITIONING AND ITS CLINICAL APPLICATION (Invited Lecture)
I.E. Konstantinov, Royal Children's Hospital, Parkville, Australia 		294
16:00 THE ROLE OF THROMBOSPONDIN-1 IN INFARCT HEALING AND CARDIAC REMODELING (Invited Lecture)
N. Frangogiannis, Baylor College of Medicine, Houston, TX, USA 		295
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
14:00 - 15:45   HALL B
 

PL12      Plenary Session
 NOVEL RISK FACTORS AND CARDIOVASCULAR DISEASE   
Chairpersons:
M.A. Alpert, St Louis, MO, USA
E.L. Barrett-Connor, La Jolla, CA, USA

 
14:00 NOVEL RISK FACTORS FOR CARDIOVASCULAR DISEASE (Invited Lecture)
E.L. Barrett-Connor, University of California, San Diego, La Jolla, CA, USA 		296
14:15 OBESITY AND MYOCARDIAL REPOLARIZATION
(Invited Lecture)
M.A. Alpert, St. John's Mercy Medical Center, St Louis, MO, USA 		297
14:30 ANTIRETROVIRALS AND CARDIOVASCULAR DISEASE (Invited Lecture)
C.J. Chen, Baylor College of Medicine, Houston, TX, USA 		298
14:45 THE RATIO OF SERUM ADIPONECTIN LEVEL TO HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE IS A POWERFUL INDEX OF METABOLIC SYNDROME IN AN AGED JAPANESE POPULATION: RESULTS FROM THE KING STUDY (Invited Lecture)
M. Yokota, Aichi-Gakuin University, Nagoya, Japan 		299
15:00 TESTOSTERONE AND CARDIOVASCULAR DISEASE: A SEX-SPECIFIC CONNECTION (Invited Lecture)
G. Laughlin, University of California, San Diego, La Jolla, CA, USA 		300
15:15 HEART RATE - WHAT ROLE IN CV RISK AND PROTECTION? (Invited Lecture)
S. Gupta, Whipps Cross and St. Bartholomew's Hospitals, Leytonstone, UK 		301
15:30 IS LOW HDL A MARKER OR A CAUSAL FACTOR FOR HEART DISEASE? (Invited Lecture)
A. Tybjaerg-Hansen, Copenhagen University Hospital, Denmark 		302
15:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
14:00 - 16:15   HALL C
 

S31        Session
 VALVULAR HEART DISEASE/ HEART VALVE SURGERY
Chairpersons:
R.W.W. Biederman, Pittsburgh, PA, USA
J.A. Elefteriades, New Haven, CT, USA

  
14:00 NORMOTHERMIC CARDIOPULMONARY BYPASS VS. DEEP HYPOTHERMIC CIRCULATORY ARREST FOR REMOVING INFERIOR VENA CAVA TUMOR THROMBUS
J.L. Navia, E.R. Nowicki, E.H. Blackstone,
N. Brozzi, F.A. Atik, J. Rajeswaran, A.M. Gillinov,
L.G. Svensson, S. Al-Ruzzeh, B.W. Lytle Cleveland Clinic, Cleveland, USA 		303
14:15 AORTIC VALVE REPLACEMENT IN HIGH-RISK PATIENT WITH SEVERE LEFT VENTRICULAR DYSFUNCTION
K. Kuwaki, A. Amano, H. Inaba, K. Tambara,
T. Yamamoto, K. Kikuchi, S. Dohi, T. Matsumura,
H. Yamaoka, A. Shimada Juntendo University, Tokyo, Japan 		 304
14:30 BOVINE ARCH – A MARKER FOR THORACIC AORTIC ANEURYSM
M. Hornick, R. Moomiaie, H. Mojibian, M. Tranquilli,
J.A. Elefteriades, Yale University School of Medicine, New Haven, CT, USA 		305
14:45 APOPTOSIS INDUCED BY AN ESCHERICHIA COLI STRAIN IN AN EXPERIMENTAL ENDOCARDITIS MODEL
J.K. Olague Franco, M. Dominguez-Hernandez,
I. Hernandez Canaveral, A. Plascencia-Hernandez,
O.M. Meilhac, University of Guadalajara, Guadalajara, Jalisco, Mexico 		306
15:00 REPEAT PERCUTANEOUS MITRAL VALVULOPLASTY (PMV) IN PATIENTS WITH RECURRENT MITRAL VALVE STENOSIS FOLLOWING TO PREVIOUS PMV (IMMEDIATE AND LONG-TERM OUTCOME)
M. Ghasemi, M. Sanatkarfar, A. Kaboli,
M.R. Movahed, Research Center Of Endovascular Intervention, Tehran, Iran 		307
15:15 DOPPLER AND CATHTER GRADIENT DISCREPANCIES IN AORTIC STENOSIS: POTENTIAL ROLE OF REYNOLDS NUMBER
J.C. Adams, P. Jiamsripong, H.P. Chaliki,
M. Belohlavek, E.M. McMahon, V. Marupakula,
J. Heys, Mayo Clinic, Scottsdale, AZ, USA 		308
15:30 DESCRIPTION OF A NOVEL EX-VIVO IMAGING AND INVESTIGATION TECHNIQUE TO RECORD, ANALYZE AND VISUALIZE HEART VALVE MOTION UNDER PHYSIOLOGICAL CONDITIONS
M. Kondruweit, S. Friedl, T. Wittenberg, R. Tandler,
M. Weyand, University-Hospital Erlangen, Fraunhofer-Institute for Integrated Circuits IIS, Erlangen, Germany 		309
15:45 THE CAUSE OF ASCENDING AORTIC DILATATION IN PATIENTS WITH BICUSPID AORTIC VALVE
F. Robicsek, R.F. Padera, M.J. Thubrikar,
K.W. Lobdell, S.C. Stamou, Sanger Heart & Vascular Institute, Carolinas Medical Center, Charlotte, NC, USA 		310
16:00 PREVALENCE OF MITRAL REGURGITATION BY FUNCTIONAL CLASS IN THE US ADULT POPULATION
A.P. Badiye, G. Robalino, J. Junttila, S. Atapattu,
M. Nakamura, E. de Marchena, University of Miami, Miami, FL, USA 		311
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
14:00 - 16:45   HALL D
 

S32     Session
 ARRHYTHMIA I: SUDDEN CARDIAC DEATH/ IMPLANTABLE ANTIARRHYTHMIC DEVICES/ PACING
Chairpersons:
F.I. Marcus, Tucson, AZ, USA
M.H. Pitzalis, Greenville, NC, USA

 
14:00 VICTIMS OF SUDDEN CARDIAC DEATH WITH AMBIGUOUS AUTOPSIES: POTENTIAL FOR ERRONEOUS INTERPRETATION?
H. Raju, M. Papadakis, M. Govindan, R. Bastiaenen,
N. Chandra, N. Edwards, A. O'Sullivan,
M.N. Sheppard, E. Behr, S. Sharma, St George's University of London, UK 		312
14:15 THE DIAGNOSTIC YIELD OF BRUGADA SYNDROME IN VICTIMS OF SUDDEN ARRHYTHMIC DEATH SYNDROME: AN UNDERESTIMATED ENTITY?
M. Papadakis, N. Chandra, H. Raju, R. Bastiaenen,
A. O’Sullivan, T. Fonseca, E. Sawyer, N. van Niekerk,
S. Sharma, St George's University of London & University Hospital Lewisham, UK 		313
14:30 C-REACTIVE PROTEIN: A NEW MARKER OF ARRHYTHMIC EVENT IN BRUGADA SYNDROME?
A. Bonny, F. Larrazet, I. Ditah, F. Hidden-Lucet,
G. Fontaine, R. Frank, Hopital Saint Camille, Bry Sur Marne, France 		314
14:45 ECG SCREENING OF 32,000 YOUNG ADULTS FOR SUDDEN CARDIAC DEATH (SCD) UTILIZING TRAINED COMMUNITY VOLUNTEERS: REPORT OF OUR EXPERIENCE
J.C. Marek, J. Davis, V. Bufalino, K. Marek, Midwest Heart Foundation, Lombard, Illinois, USA 		315
15:00 IS MINIMALLY INVASIVE LEFT VENTRICULAR EPICARDIAL LEAD IMPLANTATION THE BEST TREATMENT OPTION FOR BIVENTRICULAR PACING IN PATIENTS WITH HEART FAILURE?
J.L. Navia, N. Brozzi, F.A. Atik, E.R. Nowicki,
S. Al-Ruzzeh, E. Sepulveda, E.H. Blackstone, Cleveland Clinic, Cleveland, OH, USA 		316
15:15 SAFETY AND EFFECTIVENESS OF PRIMARY PROPHYLAXIS CARDIOVERTER-DEFIBRILLATORS IN OCTOGENERIANS
W.J. Strimel, S. Koplik, H.R. Chen, J. Song,
S.K.S. Huang Texas A&M University Health Science Center, Scott and White Hospital and Clinic: Section of Cardiac Electrophysiology and Pacing, TX, USA 		317
15:30 FALLING INCIDENCE OF VENTRICULAR FIBRILLATION INCIDENCE AMONG OUT-OF-HOSPITAL CARDIAC ARRESTS
J. Jensen, C. Torp-Pedersen, S.L. Nielsen,
G.H. Gislason, F.K. Lippert, F. Folke, Copenhagen University Hospital, Gentofte, Denmark  		 318
15:45 OLDER AGE AND ANEMIA MAY PREVENT LEFT ATRIAL REVERSE REMODELING AFTER CARDIAC RESYNCHRONIZATION THERAPY
A.S. So, H.B. Mukhtar, T. McConnell, V. Cotarlan,
C. Wenger, F. Maguire, J. Shirani, Geisinger Medical Center, Danville, PA, USA 		319
16:00 ONE-YEAR CHRONIC PERFORMANCE OF A 1.1MM ELECTRODE SPACING ATRIAL LEAD IN ICD RECIPIENTS (ASTER STUDY)
K. Seidl, K.H. Kuck, H.J. Trappe, P. Santerelli,
K. Hahlweg, F.K. Pohle, M. Simon, J. Sperzel, Cardiac Arrhythmia Institute at the Heart Centre of Ludwigshafen, Ludwigshafen, Germany 		320
16:15 RISK FACTORS FOR REHOSPITALIZATION FOR SYNCOPE AND FOR LONG-TERM MORTALITY IN 325 CONSECUTIVE PATIENTS HOSPITALIZED FOR SYNCOPE
S. Sule, C. Palaniswamy, W.S. Aronow, C. Ahn,
S.J. Peterson, S. Adapa, L. Mudambi, H. Lai,New York Medical College, Valhalla, NY, USA 		321
16:30 DIAGNOSIS OF UNEXPLAINED CARDIAC ARREST: ROLE OF LONG QT SYNDROME GENETIC SCREENING
L. Tercedor-Sanchez, J. Jimenez-Jaimez,
M. Alvarez-Lopez, R.S. Galdeano, R. Melgares-Moreno, Virgen de las Nieves Hospital, Granada, Spain 		322
16:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
MONDAY, JULY 26, 2010
16:45 - 18:45   HALL A
 

PL13    Plenary Session
HOW TO TREAT HEART FAILURE WHEN PILLS DON'T WORK ANYMORE / CARDIAC SURGERY / MECHANICAL CIRCULATORY SUPPORT
Chairpersons:
M.R. Johnson, Madison, WI, USA
D.M. Meyer, Dallas, TX, USA

 
16:45 CENTRALLY MEDIATED REGULATION OF SYMPATHETIC OUTFLOW IN HEART FAILURE: IMPROVING NO BRAKES WITH EXERCISE TRAINING? (Invited Lecture)
K.P. Patel, University of Nebraska Medical Center, Omaha, NE, USA 		323
17:00 SURGICAL TREATMENT OF HEART FAILURE: CURRENT STRATEGIES AND FUTURE DIRECTIONS (Invited Lecture)
L.P. Perrault, S. Maltais, Montreal Heart Institute, Montreal, Canada 		324
17:15

TRENDS IN HEART TRANSPLANTATION IN THE UNITED STATES - 1999 TO 2008 (Invited Lecture)
M.R Johnson, University of Wisconsin Medical School, Madison, WI, USA

325
17:30 MANENT MECHANICAL CIRCULATORY SUPPORT IN PATIENTS OF ADVANCED AGE (Invited Lecture)
R. Hetzer, German Heart Institute, Berlin, Germany 		326
17:45

CURRENT STATUS OF DESTINATION THERAPY IN THE MANAGEMENT OF END-STAGE HEART FAILURE
(Invited Lecture)
D.M. Meyer, University of Texas, Dallas, TX, USA

327
18:00 CARDIAC RESYNCHRONIZATION THERAPY: DO WE NEED A SCREENING? (Invited Lecture)
M.H. Pitzalis, The Brody School of Medicine at ECU East Carolina Heart Institute, Greenville, NC, USA 		328
18:15 IMPROVEMENT IN TWO YEAR SURVIVAL IN VENTRICULAR ASSIST DEVICE PATIENTS AFTER IMPLEMENTATION OF AN INTENSIVE SURVEILLANCE PROTOCOL (Invited Lecture)
S.V. Pamboukian, University of Alabama at Birmingham, AL, USA 		329
18:30 ULTRAFILTRATION THERAPY FOR HEART FAILURE: AN UPDATE FOR 2010 (Invited Lecture)
A. Kazory, University of Florida, Gainesville, FL, USA 		330
MONDAY, JULY 26, 2010
16:45 - 18:45   HALL B
 

PL14   Plenary Session
 CORONARY CIRCULATION - FROM PHYSIOLOGY TO CLINICAL PATHOLOGY / ISCHEMIC PRECONDITIONING    
Chairpersons:
G. Heusch, Essen, Germany
L. Kuo, Temple, TX, USA

 
16:45 WHAT IS CORONARY BLOOD FLOW RESERVE? ROLE OF CAPILLARIES (Invited Lecture)
S. Kaul, Oregon Health & Science University, Portland, OR, USA 		331
17:00 CORONARY MICROEMBOLIZATION- BEDSIDE TO BENCH AND BACK TO BEDSIDE (Invited Lecture)
G. Heusch, University of Essen Medical School, Essen, Germany		 332
17:15 REGULATION OF CORONARY MICROCIRCULATION BY ADENOSINE: FROM PHYSIOLOGY TO PATHOPHYSIOLOGY (Invited Lecture)
L. Kuo, Texas A&M Health Science Center, Temple, TX, USA		 333
17:30 VASOMOTOR SYMPTOMS AND CORONARY ARTERY CALCIUM (Invited Lecture)
M.A. Allison, University of California, San Diego, La Jolla, CA, USA MECHANISM OF ACS ONSET - INSIGHT FROM ANGIOSCOPY (Invited Lecture) Yasunori Ueda, Osaka Police Hospital, Osaka, Japan 		334
17:45 MECHANISM OF ACS ONSET - INSIGHT FROM ANGIOSCOPY (Invited Lecture)
Y. Ueda, Osaka Police Hospital, Osaka, Japan 		335
18:00 PHOSPHORYLATION OF ARC IS A CRITICAL ELEMENT IN THE ANTI-APOPTOTIC EFFECT OF ANESTHETIC PRECONDITIONING
X. Lu, P.G. Moore, H. Liu, S. Schaefer, University of California, Davis, CA, USA 		336
18:15 FISH OIL INDUCED INCREASE IN MEMBRANE PEROXIDATION POTENTIAL PARADOXICALLY PROMOTES PRECONDITIONING
P.L. McLennan, G.G. Abdukeyum, A.J. Owen,
T.A. Larkin, University of Wollongong, Wollongong, NSW, Australia		 337
18:30 REMOTE NOCICEPTOR-INDUCED CONDITIONING: PROTECTING THE HEART VIA THE SKIN
X. Ren, T. Helmy, M. Leesar, J. Rubenstein, Y. Liu,
L. Haar, T. Forde, M. Tranter, N.L. Weintraub,
W.K. Jones, University of Cincinnati, Cincinnati, OH, USA 		338
MONDAY, JULY 26, 2010
16:45 - 17:45   HALL C
 

S33   Session
 GENETIC DETERMINANTS OF HEART DISEASE, GENE AND CELL BASED THERAPIES, BASIC RESEARCH    
Chairpersons:
N.E. Bowles, Salt Lake City, UT, USA
K.N. Pandey, New Orleans, LA, USA

 
16:45 A ROLE FOR TOLL-LIKE RECEPTOR 3 VARIANTS IN HOST SUSCEPTIBILITY TO ENTEROVIRAL MYOCARDITIS AND DILATED CARDIOMYOPATHY
C. Gorbea, K.A. Makar, M. Pauschinger,
H.P. Schultheiss, J.A. Towbin, J.G. Vallejo,
N.E. Bowles, University of Utah, Salt Lake City, UT, USA 		339
17:00 THE 4399MET ALLELE OF THE LPA GENE EXPLAINS THE ASSOCIATION BETWEEN THE CCTC HAPLOTYPE AND CORONARY HEART DISEASE
D. Shiffman, J.Z. Louie, C.M. Rowland, M.J. Malloy,
J.P. Kane, J.J. Devlin Celera, Alameda, CA, USA 		340
17:15 MYOCARDIAL REGENERATION STUDY: IN VITRO COMPARISON OF HUMAN FETAL PLACENTA VERSUS BONE MARROW DERIVED MESECHYMAL STEM CELLS
D. Xu, M.N. Duong, B.L. Yen, C. Renzo, R. Chiu, McGill University-Montreal General Hospital, Montreal, QC, Canada 		341
17:30 REGENERATION OF INFRACTED MYOCARDIUM WITH NUTRITIONALLY MODIFIED CARDIAC STEM CELLS
D.K. Das, Cardiovascular Research Center, University of Connecticut, CT, USA 		343
MONDAY, JULY 26, 2010
16:45 - 19:30   HALL D
 

S34   Session
 ARRHYTHMIA II: DIAGNOSES, DRUG THERAPY/ ABLATION   
Chairpersons:
F. Duru, Switzerland
A. Roth, Tel Aviv, Israel

 
16:45 CLINICAL IMPACT OF IMAGE INTEGRATION SYSTEM FOR CATHETER ABLATION OF PERSISTENT/PERMANENT ATRIAL FIBRILLATION
P.F. Pollice, F.A. Fabiani, S.E. Saad, P.P. Pollice, University of Berne, Switzerland 		344
17:00 PREDICTORS AND OUTCOME OF HOSPITALIZED PATIENTS WITH ATRIAL FIBRILLATION AND ELEVATED CARDIAC ENZYMES
K.L. Vinales, H.P. Chaliki, M.Q. Najib,
P. Surapaneni, V. Marupakula, Mayo Clinic, Scottsdale, AZ, USA		 345
17:15 ATRIAL FIBRILLATION: HOW FAR WE ARE FROM IDEAL MANAGEMENT?
A. Shah, V. Manglam, V. Sharma, H. Singh,
N.P. Waterfield, S.D. Rosen, C.M. Bellamy, Glan Clwyd Hospital, Bodelwyddan, London, UK		 346
17:30 ABLATION OF PERSISTENTLY INDUCIBLE AV NODAL REENTRY TACHYCARDIA UTILIZING A LEFT ATRIAL APPROACH
R.C. Klein, McKay-Dee Hospital Center, Ogden, Utah, USA 		347
17:45 THE RELATIONSHIP OF LEFT ATRIUM LINEAR DIMENSIONS TO LEFT ATRIUM VOLUME MEASURED BY CARDIAC MULTI-DETECTOR COMPUTED TOMOGRAPHY (MDCT) IN PATIENTS WITH ATRIAL FIBRILLATION
E.A. Charaf, S. Verma, University of South Alabama, Mobile, Alabama, USA		 348
18:00 DO ALL ATRIAL FIBRILLATION PATIENTS REQUIRE IN-HOSPITAL LOADING OF DOFETILIDE AND SOTALOL?
K. Agusala, A. Oesterle, T. Caprio, R. Passman, Northwestern Memorial Hospital, Chicago, IL, USA 		349

   

 

Sunday,
July 25, 2010		 Monday,
July 26, 2010		 Tuesday,
July 27, 2010
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions